Dexcom Inc
NASDAQ:DXCM
Dexcom Inc
NASDAQ:DXCM
Price:
124.34 USD
-9.91%
Market Closed
Updated:
Apr 28, 2024
Dexcom Inc
Cost of Revenue
|
Dexcom Inc
Cost of Revenue Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Dexcom Inc
NASDAQ:DXCM
|
Cost of Revenue
-$1.3B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-36%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cost of Revenue
-$11.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-11%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cost of Revenue
-$4.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-6%
|
|
|
Stryker Corp
NYSE:SYK
|
Cost of Revenue
-$7.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cost of Revenue
-$18.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cost of Revenue
-$2.5B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-14%
|
See Also
What is Dexcom Inc's Cost of Revenue?
Cost of Revenue
-1.3B
USD
-1.3B
USD
Based on the financial report for Dec 31, 2023, Dexcom Inc's Cost of Revenue amounts to -1.3B USD.
What is Dexcom Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-36%
-36%
Over the last year, the Cost of Revenue growth was -30%. The average annual Cost of Revenue growth rates for Dexcom Inc have been -28% over the past three years , -29% over the past five years , and -36% over the past ten years .
You don't have any saved screeners yet
